|
|
Volumn 20, Issue 2, 2002, Pages 101-108
|
|
Cost-effectiveness analysis of exemestane compared with megestrol in advanced breast cancer: A model for Europe and Australia
a
c
Pharmacia Corp
(Italy)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
EXEMESTANE;
MEGESTROL;
TAMOXIFEN;
ADVANCED CANCER;
ARTICLE;
AUSTRALIA;
BELGIUM;
BREAST CARCINOMA;
CALCULATION;
CANCER HORMONE THERAPY;
CANCER SURVIVAL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
COST EFFECTIVENESS ANALYSIS;
DISEASE MODEL;
DISEASE SIMULATION;
DOUBLE BLIND PROCEDURE;
DRUG COST;
FEMALE;
FRANCE;
GERMANY;
HUMAN;
ITALY;
MAJOR CLINICAL STUDY;
MULTICENTER STUDY;
NETHERLANDS;
PHASE 3 CLINICAL TRIAL;
POSTMENOPAUSE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SPAIN;
UNITED KINGDOM;
|
|
EID: 0036206298
PISSN: 11707690
EISSN: None
Source Type: Journal
DOI: 10.2165/00019053-200220020-00003 Document Type: Article |
|
Times cited : (20)
|
|
References (7)
|
